METASTATIC NRG-BR002

Study #NRG-BR002

A Phase IIR/III Trial of Standard of Care Therapy with or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

Back To Clinical Trials